Again, what we see is that very low or very high values—when extreme enough—can sometimes offer predictive value. It's in the extremes that we occasionally find meaningful guidance.

My name is Professor Anders Perner, and I'm based at Copenhagen University Hospital in Denmark. At this year's IFAD meeting, I participated in a Pro/Con debate on the use of central venous pressure (CVP) monitoring, where I presented the argument in favor of CVP.

I believe the IFAD Congress is an outstanding opportunity to engage with colleagues, friends, and experts from around the world and to have focused, high-level discussions on one of the most critical aspects of intensive care: fluid therapy.

In many ways, this meeting has found the perfect balance—its size, its focus, and the setting all contribute to creating an ideal environment for sharing ideas, challenging assumptions, and improving the care of our sickest patients.